SLG
37
6
BK
77
2
FSLR
60
-10
HPE
68
-5
SIG
52
2
ROK
47
-3
A
46
2
EL
59
-2
CNP
55
3
COST
53
5
FITB
72
2
VNO
52
2
GS
78
2
UA
38
3
MCD
46
4
EXPD
48
-2
ALL
61
-2
PM
56
2
XRAY
28
3
ETR
52
3
SLG
37
6
BK
77
2
FSLR
60
-10
HPE
68
-5
SIG
52
2
ROK
47
-3
A
46
2
EL
59
-2
CNP
55
3
COST
53
5
FITB
72
2
VNO
52
2
GS
78
2
UA
38
3
MCD
46
4
EXPD
48
-2
ALL
61
-2
PM
56
2
XRAY
28
3
ETR
52
3
Financhill
Back

Ülker Bisküvi Sanayi AS Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
42

UELKY
Ülker Bisküvi Sanayi AS

Last Price:
$25.15
Seasonality Move:
22.62%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Sell
42
Ülker Bisküvi Sanayi AS (UELKY) is a Sell

Is Ülker Bisküvi Sanayi AS a Buy, Sell or Hold?

  • The current Ülker Bisküvi Sanayi AS [UELKY] share price is $25.15. The Score for UELKY is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • UELKY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

UELKY Stock Price Chart

What is Ülker Bisküvi Sanayi AS's stock price today?

  • The Ülker Bisküvi Sanayi AS share price today is $25.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UELKY is experiencing slight buying pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

UELKY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.62 Buy
Relative Strength Index (14 RSI): 39.68 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.79 - 26.93) Sell
Bollinger Bands (100): (25.58 - 26.7) Sell

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

UELKY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.15 Sell
20-day SMA: 25.77 Sell
50-day SMA: 26.05 Sell
200-day SMA: 26.97 Sell
8-day EMA: 19.58 Buy
20-day EMA: 11.35 Buy
50-day EMA: 5.37 Buy
200-day EMA: 1.46 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Ülker Bisküvi Sanayi AS Earnings Growth & UELKY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Ülker Bisküvi Sanayi AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):